Every day, researchers around the world work tirelessly to unlock discoveries with mammalian cell culture experiments yet the full potential of this work remains untapped. Optimizing cellular health with adjustments to individual media components has established value to scientific results. One problem is that adjusting media to control for each variable is so much work. Along the same lines, it’s rare for labs to evaluate the material waste streams they generate by using commercial, off-the-shelf tissue culture media. The good news is that exciting progress in the field of cell and gene therapies is driving accessible economies of scale in cell culture experimentation.